These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20339367)

  • 1. Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.
    Knudsen KL; Blank SK; Burt Solorzano C; Patrie JT; Chang RJ; Caprio S; Marshall JC; McCartney CR
    Obesity (Silver Spring); 2010 Nov; 18(11):2118-24. PubMed ID: 20339367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.
    McCartney CR; Prendergast KA; Chhabra S; Eagleson CA; Yoo R; Chang RJ; Foster CM; Marshall JC
    J Clin Endocrinol Metab; 2006 May; 91(5):1714-22. PubMed ID: 16492701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Resistance, Hyperinsulinemia, and LH: Relative Roles in Peripubertal Obesity-Associated Hyperandrogenemia.
    Burt Solorzano CM; Knudsen KL; Anderson AD; Hutchens EG; Collins JS; Patrie JT; Marshall JC; McCartney CR
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2571-2582. PubMed ID: 29897474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.
    McCartney CR; Blank SK; Prendergast KA; Chhabra S; Eagleson CA; Helm KD; Yoo R; Chang RJ; Foster CM; Caprio S; Marshall JC
    J Clin Endocrinol Metab; 2007 Feb; 92(2):430-6. PubMed ID: 17118995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity on hyperandrogenemia in Korean girls.
    Kang MJ; Yang S; Hwang IT
    Ann Pediatr Endocrinol Metab; 2016 Dec; 21(4):219-225. PubMed ID: 28164075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH; Qiao J; Li MZ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
    Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls.
    McCartney CR; Prendergast KA; Blank SK; Helm KD; Chhabra S; Marshall JC
    J Clin Endocrinol Metab; 2009 Jan; 94(1):56-66. PubMed ID: 18957503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
    El-Khayat HA; Abd El-Basset FZ; Tomoum HY; Tohamy SM; Zaky AA; Mohamed MS; Hakky SM; El Barbary NS; Nassef NM
    Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.
    Spritzer PM; Poy M; Wiltgen D; Mylius LS; Capp E
    Hum Reprod; 2001 Jul; 16(7):1340-6. PubMed ID: 11425810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
    Dale PO; Tanbo T; Vaaler S; Abyholm T
    Fertil Steril; 1992 Sep; 58(3):487-91. PubMed ID: 1521640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-Oxygenated C19 Steroids Do Not Distinguish the Hyperandrogenic Phenotype of PCOS Daughters from Girls with Obesity.
    Torchen LC; Sisk R; Legro RS; Turcu AF; Auchus RJ; Dunaif A
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e3903-9. PubMed ID: 32797203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted day-night changes in luteinizing hormone pulse frequency in girls with obesity: the potential role of hyperandrogenemia.
    Collins JS; Beller JP; Burt Solorzano C; Patrie JT; Chang RJ; Marshall JC; McCartney CR
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2887-96. PubMed ID: 24780043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.